Drawbacks: Injection Discomfort: Some patients may have a fear of needles or find injections uncomfortable
The market is expected to grow from $65,865.6 million in 2025 to $139,268.4 million in 2030 at a rate of 16.2%
When you compare options, remember Tonums research-backed oral approach is designed for people who prefer evidence-backed, non-injectable choices
Compounded semaglutide still saves $150 per month ($1,800 annually), but the decision is no longer as clear-cut
A pregnancy registry collects information about the safety of certain drugs when used during pregnancy
They must demonstrate consistent quality control, proper equipment calibration, and adherence to United States Pharmacopeia (USP) standards for compounding